These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 5863643)

  • 1. [Experiences with a new cytostatic of the methylhydrazine series (Natulan). With special reference to hematological side-effects].
    Kummer H; Bucher U
    Schweiz Med Wochenschr; 1965 Sep; 95(37):1233-40. PubMed ID: 5863643
    [No Abstract]   [Full Text] [Related]  

  • 2. [A fundamentally new cytostatic: a methylhydrazine derivative (Natulan)].
    Hansen MM; Hertz H
    Ugeskr Laeger; 1966 Mar; 128(11):313-6. PubMed ID: 5331165
    [No Abstract]   [Full Text] [Related]  

  • 3. [Chemotherapy of malignant systemic diseases with a methylhydrazine derivative, Natulan].
    Nissen I; Poulsen EH
    Ugeskr Laeger; 1967 Nov; 129(44):1472-6. PubMed ID: 4875225
    [No Abstract]   [Full Text] [Related]  

  • 4. [A new methylhydrazine derivative (Ro 4-6467 or Natulan) in the treatment of Hodgkin's disease. Study of 10 cases].
    da Silva MP; Kerbauy J; de Guerra CC
    Rev Bras Med; 1966 Jul; 23(7):483-9. PubMed ID: 6014416
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical experiences with a methylhydrazine derivative (Natulan)].
    Hertz H; Hansen MM; Videbaek AA
    Ugeskr Laeger; 1966 Mar; 128(11):316-24. PubMed ID: 5331015
    [No Abstract]   [Full Text] [Related]  

  • 6. [First clinical experiences with methylhydrazine in treatment of malignant lymphogranuloma].
    Fazio M; Cavallero P; Sartoris S; Vergnano F; Pegoraro L
    Minerva Med; 1965 Dec; 56(99):4338-43. PubMed ID: 5323491
    [No Abstract]   [Full Text] [Related]  

  • 7. [p-(N'-Methylene-hydrazinomethyl)-N-isopropylbenzamide (methylhydrazine) in the treatment of systemic non-leukemic lymphatic diseases].
    Grignani F; Mastrodicasa M; Colonna A; Tonato M; Martelli M
    Clin Ter; 1966 May; 37(4):325-41. PubMed ID: 5926019
    [No Abstract]   [Full Text] [Related]  

  • 8. [Medical treatment of Dupuytren's disease with a cytostatic agent (methylhydrazine)].
    Aron E
    Presse Med (1893); 1968 Oct; 76(41):1956. PubMed ID: 5724620
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical observations on the short-term effects of a synthetic antiblastic agent, a derivative of methylhydrazine, with or without radiotherapy].
    Massenti S; Perri G
    Minerva Radiol; 1967 Apr; 12(4):140-4. PubMed ID: 5613803
    [No Abstract]   [Full Text] [Related]  

  • 10. [Observations on the use of a recent antineoplastic drug (methylhydrazine) associated with radiotherapy].
    Agati G
    Minerva Radiol; 1968 Sep; 13(9):470-8. PubMed ID: 5726968
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparative results in 80 cases of cancer of the esophagus treated either by telecobalt or by a telecobalt-methylhydrazine combination].
    Robillard J; Couedic Y
    J Radiol Electrol Med Nucl; 1967 Dec; 48(12):867-71. PubMed ID: 5584090
    [No Abstract]   [Full Text] [Related]  

  • 12. Procarbazine (Natulan) and busulfan in the treatment of polycythemia vera.
    Penttilä O; Ikkala E
    Ann Med Intern Fenn; 1968; 57(2):99-101. PubMed ID: 5706392
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical experience with ibenzmethyzin (Natulan) in the treatment of lymphomas and solid tumours.
    Holsti LR; Hjelt AL
    Ann Med Intern Fenn; 1967; 56(3):119-24. PubMed ID: 5630600
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical experiences with the cytostatic drug natulan].
    Kohout J
    Med Klin; 1969 May; 64(19):898-901. PubMed ID: 5819002
    [No Abstract]   [Full Text] [Related]  

  • 15. [Our experience in the treatment of Hodgkin's disease and other reticulopathies with Ro4-6467 (Natulan)].
    Arroyo de la Fuente F; Lasheras Garde J; Triginer Boixeda J
    Sangre (Barc); 1966; 11(3):265-70. PubMed ID: 6012465
    [No Abstract]   [Full Text] [Related]  

  • 16. [Experiences with Natulan in the treatment of lymphogranulomatosis and reticulosarcomatosis].
    Wagner K; Haas H; Meyerhold A
    Wien Klin Wochenschr; 1965 Sep; 77(36):589-602. PubMed ID: 5323247
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of some chronic hemoblastoses by a derivative of methylhydrazine (Natulan)].
    Quattrin N; Montuori R
    Acta Genet Med Gemellol (Roma); 1968 Jan; 17(1):178-9. PubMed ID: 4968995
    [No Abstract]   [Full Text] [Related]  

  • 18. [The action of Natulan in 94 cases of solid tumors].
    Kenis Y; De Smedt J; Tagnon HJ
    Eur J Cancer (1965); 1966 Feb; 2(1):51-7. PubMed ID: 5962294
    [No Abstract]   [Full Text] [Related]  

  • 19. [Recent cytostatic therapy in hemoblastosis and malignant tumors].
    Kühböck J; Mannheimer E
    Wien Klin Wochenschr; 1966 Jul; 78(26):487-8. PubMed ID: 5992456
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical data on the antitumor activity of hydrazine sulfate.
    Gershanovich ML; Danova LA; Kondratyev VB; Malyugina LL; Stukov AN; Seitz JF; Filov VA
    Cancer Treat Rep; 1976 Jul; 60(7):933-5. PubMed ID: 1009524
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.